41 – 50 of 124
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Do variants in IRF2BPL cause both neurological disorders and keratoconus 8?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
- Contribution to journal › Article
-
Mark
Disappearance of familially aggregated paralysis agitans in subsequent generations: a 135-year follow up study
- Contribution to journal › Published meeting abstract
-
Mark
Long term outcome of Parkinson’s disease and validation of a new clinical classification system.
- Contribution to journal › Published meeting abstract
-
Mark
Ataxia project in Scania, Sweden: Study outline and current status
- Contribution to journal › Published meeting abstract
-
Mark
Co-occurrence of leukoencephalopathy with ataxia and SPG56 in one family
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
- Contribution to journal › Article
-
Mark
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
- Contribution to journal › Letter
-
Mark
Nationwide prevalence of primary dystonia, progressive ataxia and hereditary spastic paraplegia
- Contribution to journal › Article
- 2018
-
Mark
SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies
- Contribution to journal › Article
